Literature DB >> 25485940

The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo.

Malcolm P Hilton1, Darren K Pinder.   

Abstract

BACKGROUND: This is an update of a Cochrane Review first published in The Cochrane Library in Issue 1, 2002 and previously updated in 2004 and 2007.Benign paroxysmal positional vertigo (BPPV) is a syndrome characterised by short-lived episodes of vertigo in association with rapid changes in head position. It is a common cause of vertigo presenting to primary care and specialist otolaryngology clinics. Current treatment approaches include rehabilitative exercises and physical manoeuvres, including the Epley manoeuvre.
OBJECTIVES: To assess the effectiveness of the Epley manoeuvre for posterior canal BPPV. SEARCH
METHODS: We searched the Cochrane Ear, Nose and Throat Disorders Group Trials Register; CENTRAL; PubMed; EMBASE; CINAHL; Web of Science; Cambridge Scientific Abstracts; ICTRP and additional sources for published and unpublished trials. The date of the most recent search was 23 January 2014. SELECTION CRITERIA: Randomised controlled trials of the Epley manoeuvre versus placebo, no treatment or other active treatment for adults diagnosed with posterior canal BPPV (including a positive Dix-Hallpike test). The primary outcome of interest was complete resolution of vertigo symptoms. Secondary outcomes were conversion of a 'positive' Dix-Hallpike test to a 'negative' Dix-Hallpike test and adverse effects of treatment. DATA COLLECTION AND ANALYSIS: We used the standard methodological procedures expected by The Cochrane Collaboration. MAIN
RESULTS: We included 11 trials in the review with a total of 745 patients.Five studies compared the efficacy of the Epley manoeuvre against a sham manoeuvre, three against other particle repositioning manoeuvres (Semont, Brandt-Daroff and Gans) and three against a control (no treatment, medication only, postural restriction). Patients were treated in hospital otolaryngology departments in eight studies and family practices in two studies. All patients were adults aged 18 to 90 years old, with a sex ratio of 1:1.5 male to female.There was a low risk of overall bias in the studies included. All studies were randomised with six applying sealed envelope or external allocation techniques. Eight of the trials blinded the assessors to the participants' treatment group and data on all outcomes for all participants were reported in eight of the 11 studies. Complete resolution of vertigo Complete resolution of vertigo occurred significantly more often in the Epley treatment group when compared to a sham manoeuvre or control (odds ratio (OR) 4.42, 95% confidence interval (CI) 2.62 to 7.44; five studies, 273 participants); the proportion of patients resolving increased from 21% to 56%. None of the trials comparing Epley versus other particle repositioning manoeuvres reported vertigo resolution as an outcome. Conversion of Dix-Hallpike positional test result from positive to negative Conversion from a positive to a negative Dix-Hallpike test significantly favoured the Epley treatment group when compared to a sham manoeuvre or control (OR 9.62, 95% CI 6.0 to 15.42; eight studies, 507 participants). There was no difference when comparing the Epley with the Semont manoeuvre (two studies, 117 participants) or the Epley with the Gans manoeuvre (one study, 58 participants). In one study a single Epley treatment was more effective than a week of three times daily Brandt-Daroff exercises (OR 12.38, 95% CI 4.32 to 35.47; 81 participants). Adverse effects Adverse effects were infrequently reported. There were no serious adverse effects of treatment. Rates of nausea during the repositioning manoeuvre varied from 16.7% to 32%. Some patients were unable to tolerate the manoeuvres because of cervical spine problems. AUTHORS'
CONCLUSIONS: There is evidence that the Epley manoeuvre is a safe, effective treatment for posterior canal BPPV, based on the results of 11, mostly small, randomised controlled trials with relatively short follow-up. There is a high recurrence rate of BPPV after treatment (36%). Outcomes for Epley manoeuvre treatment are comparable to treatment with Semont and Gans manoeuvres, but superior to Brandt-Daroff exercises.

Entities:  

Mesh:

Year:  2014        PMID: 25485940     DOI: 10.1002/14651858.CD003162.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  47 in total

1.  Effectiveness of the Epley manoeuvre in posterior canal benign paroxysmal positional vertigo: a randomised clinical trial in primary care.

Authors:  José Luis Ballvé; Ricard Carrillo-Muñoz; Yolanda Rando-Matos; Iván Villar; Oriol Cunillera; Jesús Almeda; Estrella Rodero; Xavier Monteverde; Carles Rubio; Noemí Moreno; Olga Lucia Arias; Carlos Martin; Rafael Azagra
Journal:  Br J Gen Pract       Date:  2018-12-03       Impact factor: 5.386

Review 2.  Evaluating the Epley maneuver.

Authors:  Emélie Braschi; David Ross; Christina Korownyk
Journal:  Can Fam Physician       Date:  2015-09       Impact factor: 3.275

3.  Evaluating the Epley maneuver.

Authors:  Emélie Braschi; David Ross; Christina Korownyk
Journal:  Can Fam Physician       Date:  2015-10       Impact factor: 3.275

4.  Vestibular rehabilitation therapy in Europe: chances and challenges.

Authors:  Klaus Jahn; Christophe Lopez; Andreas Zwergal; Oz Zur; Ondrej Cakrt; Silvy Kellerer; Hassen Kerkeni; Fredrik Tjernström; Dara Meldrum
Journal:  J Neurol       Date:  2019-05-17       Impact factor: 4.849

Review 5.  Teaching Patient-Centered Counseling Skills for Assessment, Diagnosis, and Management of Benign Paroxysmal Positional Vertigo.

Authors:  Anna Marie Jilla; Richard A Roberts; Carole E Johnson
Journal:  Semin Hear       Date:  2018-02-07

6.  Two-Hour Follow-Up is Equivalent to One-Day Follow-Up of Posterior Canal Benign Paroxysmal Positional Vertigo.

Authors:  Yalçın Alimoğlu; Fazilet Altın; Reşit Murat Açıkalın; Hüsamettin Yaşar
Journal:  J Int Adv Otol       Date:  2019-04       Impact factor: 1.017

7.  An Educational Intervention for Acute Dizziness Care: A Randomized, Vignette-based Study.

Authors:  William J Meurer; Patricia Johnson; Devin Brown; Alexander Tsodikov; Brigid Rowell; Angela Fagerlin; Steven A Telian; Laura Damschroder; Lawrence C An; Lewis B Morgenstern; Kevin A Kerber
Journal:  Otol Neurotol       Date:  2019-09       Impact factor: 2.311

8.  Barriers and facilitators to ED physician use of the test and treatment for BPPV.

Authors:  Kevin A Kerber; Jane Forman; Laura Damschroder; Steven A Telian; Angela Fagerlin; Patricia Johnson; Devin L Brown; Lawrence C An; Lewis B Morgenstern; William J Meurer
Journal:  Neurol Clin Pract       Date:  2017-06

9.  Implementation of Evidence-Based Practice for Benign Paroxysmal Positional Vertigo in the Emergency Department: A Stepped-Wedge Randomized Trial.

Authors:  Kevin A Kerber; Laura Damschroder; Thomas McLaughlin; Devin L Brown; James F Burke; Steven A Telian; Alexander Tsodikov; Angela Fagerlin; Lawrence C An; Lewis B Morgenstern; Jane Forman; Sandeep Vijan; Brigid Rowell; William J Meurer
Journal:  Ann Emerg Med       Date:  2019-12-20       Impact factor: 5.721

Review 10.  Betahistine for symptoms of vertigo.

Authors:  Louisa Murdin; Kiran Hussain; Anne G M Schilder
Journal:  Cochrane Database Syst Rev       Date:  2016-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.